Clinical trial · Interventional
Virtual Reality to Promote Relaxation Prior to Simulation
Virtual Reality to Promote Mindfulness and Relaxation Prior to Radiation Simulation: A Prospective Pilot Feasibility Study
NCT06318338CI-TRIAL-00106519completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to assess the feasibility of a pre-simulation virtual reality (VR) platform designed to promote relaxation for cancer patients planned for radiation therapy (RT).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Virtual Reality Program | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Virtual Reality Program
- description
- This is a single arm study. All participants will participate in the study intervention, which involves experiencing a virtual reality program.
- interventionNames
- Other: Virtual Reality Program
Primary outcomes (1)
- measure
- Feasibility of a Pre-simulation VR Platform Prior to Radiation
- timeFrame
- 1 Day
- description
- Feasibility based on the ability of at least 75% patient VR completion rate. Based on the expected accrual of 25 patients, futility and early termination will be triggered if six participants fail to meet the conditions described above.
Secondary outcomes (2)
- measure
- Patient Situational Anxiety Prior to and After Use of VR Program (HADS)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Able to understand, read or speak English sufficient for signing of informed consent and completion of study assessments 2. Patients scheduled for simulation for radiation treatment planning at Perelman Center for Advanced Medicine (PCAM) 3. Adults, at least 18 years of age 4. Performance Status (ECOG) 0-2 Exclusion Criteria: 1. Prior radiotherapy 2. History of motion sickness, car sickness, vertigo, migraines, or light sensitivity within the last 6 months 3. History of epilepsy and seizures 4. Current nausea, vomiting, dizziness, lightheadedness, monocular vision or hearing loss that is not treated
References
Publications (0)
Data not yet available
No reference posted for this study.